IFRX · NASDAQ
InflaRx (IFRX) Stock Price & Fundamentals
InflaRx (IFRX) closed at $957.53 on Oct 9, 2026, up 1.53% from the previous close of $943.13.
Share price, past year
1Y +10.18%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $957.53 |
| Sep 30, 2026 | $926.71 |
| Aug 31, 2026 | $901.27 |
| Jul 31, 2026 | $836.92 |
| Jun 30, 2026 | $831.61 |
| May 29, 2026 | $791.11 |
| Apr 30, 2026 | $799.70 |
| Mar 31, 2026 | $773.52 |
| Feb 27, 2026 | $746.61 |
| Jan 30, 2026 | $789.92 |
| Dec 31, 2025 | $844.22 |
| Nov 28, 2025 | $845.04 |
| Oct 31, 2025 | $883.71 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 72.3M
- Dividend yield
- —
- 52-week range
- $746.61 – $957.53
Market cap, P/E and dividend yield aren't shown for InflaRx yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in euros.
Financials
InflaRx reported revenue of €165.79K for fiscal 2024, up 162.79% from fiscal 2023.
Figures are in euros (EUR), as InflaRx reports them to the SEC.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | €165.79K | +162.8% | — | — | −€0.78 | — |
| FY2023ended Dec 31, 2023 | €63.09K | — | — | — | −€0.78 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | €39.43K | — | −€0.21 |
| Q2 FY2024ended Jun 30, 2024 | €6.36K | — | −€0.24 |
Company profile
- Name
- InflaRx N.V.
- Ticker
- IFRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Winzerlaer Str. 2, Jena, 2M 07745
- Incorporated in
- P7
- Fiscal year ends
- December
- SEC CIK
- 0001708688
Recent SEC filings
- Mar 20, 2026
- Mar 20, 2025
- Mar 21, 2024
- Mar 22, 2023
- Mar 24, 2022
- Mar 25, 2021
- Apr 29, 2020
- Mar 29, 2019
Frequently asked questions
What is InflaRx's stock price?
InflaRx (IFRX) closed at $957.53 on Oct 9, 2026, up 1.53% from the previous close of $943.13.
How much revenue does InflaRx make?
InflaRx reported revenue of €165.79K for fiscal 2024, up 162.79% from fiscal 2023.
Sources and methodology
Fundamentals come from InflaRx N.V.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures